Immutable Holdings Announces Voting Results for Its Annual General Meeting of Shareholders
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Immutable Holdings Inc. (NEO:HOLD) (“Immutable…
11TH ANNUAL WINTERNATIONAL EMBASSY SHOWCASE DRAWS 8,000 GUESTS
68 Embassies Displayed Their Culture and Traditions at the Ronald Reagan Building…
Digitalist Group Plcs Financial Reporting and Annual General Meeting in 2025
December 20, 2024 02:00 ET | Source: Digitalist Group Oyj Digitalist Group…
Dream Finders Homes Releases 2023 Annual Shareholder Letter
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Dream Finders Homes, Inc. (the “Company” or “DFH”) (NYSE: DFH),…
ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Garching / Munich, Germany, December 13, 2024 – ITM Isotope Technologies Munich SE…
PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included…
Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included…
Orca Bio Presents Clinical Results on Use of Orca-Q without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
Orca-Q allogeneic T-cell immunotherapy with no GvHD prophylaxis in patients with matched…
MiNA Therapeutics Presents New Pre-Clinical Data from Lead Sickle Cell Disease Program at the American Society of Hematology Annual Meeting
MTL-HBG drug candidate demonstrated best-in-class activity and safety in pre-clinical models Data…
Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting
December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK,…